Coverage
-
May 18, 2020
A California federal judge granted Otsuka America Pharmaceutical Inc. a win Monday in a woman's lawsuit claiming the drugmaker failed to warn her about the long-term health risks of taking low doses of the antipsychotic drug Abilify for depression, saying the suit "founders on a lack of proof."
1 other articles on this case.
View all »